Gasper J.LaRosa

Partner

New York + 1.212.326.7885

Gasper LaRosa is a leading pharmaceutical and biotechnology patent lawyer as recognized by clients and his peers. He has more than 20 years of client-focused experience litigating high-profile patent infringement cases involving pharmaceutical products, medical devices, chemical manufacturing processes, and battery technology. He has tried patent cases to juries and to the bench in several federal district courts and the International Trade Commission (ITC). In addition, Gasper has broad experience representing clients as lead counsel in United States Patent and Trademark Office (USPTO) post-grant proceedings.

Gasper's practice focuses particularly on Hatch-Waxman (ANDA), biosimilar (BPCIA), and other patent litigation on behalf of pharmaceutical and biotechnology companies. He has represented major pharmaceutical companies in the enforcement of patents covering some of the world's most successful drug products and drug delivery systems. His representations include litigations and Patent Trial and Appeal Board (PTAB) proceedings concerning biologics (e.g., conjugate vaccines) as well as small molecule blockbuster drugs including, Tagrisso® (treatment of non-small cell lung cancer), OxyContin® (oxycodone hydrochloride extended release tablets), Butrans® (buprenorphine patch, extended release), Androgel ® (transdermal testosterone replacement therapy), Thalomid® (a treatment of multiple myeloma and erythema nodosum leprosum), Revlimid®, Skelaxin® (a muscle relaxant), Avinza® (an extended release morphine sulphate pain reliever), and Univasc® and Uniretic ® (ACE inhibitors).

Gasper is a member of the American Bar Association, the PTAB Bar Association, the Federal Circuit Bar Association, the New York Intellectual Property Law Association, and the American Institute of Chemical Engineers.